Colman R. Kraff, MD, shares highlights of a study evaluating the safety and efficacy of the use of the iDesign 2.0 Refractive Studio for the treatment of patients with hyperopia and myopia.
Colman R. Kraff, MD, of Kraff Eye Institute (Chicago, IL), shares highlights of a study evaluating the safety and efficacy of the use of the iDesign 2.0 Refractive Studio, a new topography-integrated, wavefront-guided LASIK procedure, for the treatment of patients with hyperopia and myopia.
Disclaimer/Notes: Dr. Kraff presented this data on behalf of the International Medical Advisory Board for Optical Express. This study was conducted in the United Kingdom and Ireland.
